MSI-H Colorectal Cancer
Who we are
Efficacy and Safety of Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI Metastatic Colorectal Cancer ( NIPISAFE )
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
